Scott Mendel

Scott joined the Akoya Biosciences Board of Directors in June 2021, bringing over 25 years of experience in the diagnostics industry. He currently serves as CEO and President of GenMark Diagnostics, a highly innovative and successful molecular diagnostics company acquired by multinational healthcare company Roche. Scott joined GenMark as CFO in 2014 and was promoted to CEO in 2020. Prior to GenMark, he held senior-level leadership positions with The Active Network and GE Healthcare. Scott earned a B.S. in finance from Indiana University and an M.B.A. from Northwestern University’s Kellogg School of Management.